-
-
-
-
-
-
-
Spectral Medical gets FDA feedback on PMX device application
-
-
-
-
-
-
-
Optimi Health to start Phase 2 psilocybin trial for depression
-
-
-
-
-
-
-
Medicus Pharma publishes Phase 2 SkinJect study report
-
-
-
-
-
-
-
Definium to present Phase 3 DT120 trial data at Psych Congress 2026
-
-
-
-
-
-
-
Quantum BioPharma gets FDA clearance for MS drug trial
-
-
-
-
-
-
-
Context Therapeutics doses first patient in CT-202 Phase 1 trial
-
-
-
-
-
-
-
Pyxis Oncology reports Phase 1 data for head and neck cancer drug
-
76,965 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

